Profil
Judith Segall is the founder of Lineage Cell Therapeutics, Inc. which was founded in 1990.
She held the title of Vice President-Administration from 2016 to 2019.
Currently, she is the Secretary & Director-Administration at AgeX Therapeutics, Inc. since 2017.
Ms. Segall has also worked as Secretary & Director at Asterias Biotherapeutics, Inc. and as Secretary at OncoCyte Corp.
Ms. Segall received her undergraduate degree from the University of California, Berkeley in 1989.
Anciens postes connus de Judith Segall
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Fondateur | 01/08/2019 |
| AGEX THERAPEUTICS, INC. | Directeur Administratif | - |
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Secrétaire Général | - |
| ASTERIAS BIOTHERAPEUTICS INC | Directeur/Membre du Conseil | - |
Formation de Judith Segall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
















